VIRGINIA BEACH, Va., Jan. 26 /PRNewswire/ -- LifeNet announced today it has expanded its alliance with St. Jude Medical to include vascular allografts from LifeNet for the treatment of coronary artery disease. Under the contract expansion, St. Jude Medical will have exclusive rights for all LifeNet cardiac-based vascular allografts for their physician customer base.
Currently, St. Jude Medical has exclusive rights for all LifeNet cardiac allograft products. St. Jude Medical and LifeNet first formed their alliance in 1996.
Dr. Richard L. Hurwitz, President and CEO of LifeNet, stated, “Through our alliance with St. Jude Medical, LifeNet has grown to become the nation’s largest supplier of cardiac allografts. This new representation extension will further LifeNet’s leadership position in the cardiovascular allograft market.”
LifeNet is the nation’s largest full service Organ Procurement Organization and tissue-banking system providing more than 250,000 allograft transplants per year. For more information on LifeNet, please visit LifeNet’s website at http://www.lifenet.org.
LifeNet
CONTACT: Douglas B. Wilson of LifeNet, +1-800-847-7831
Web site: http://www.lifenet.org//
